Nucleic Acid Testing Market: By Technique (Probe Amplification, Target Amplification, Signal Amplification), By Application (Cancer, Infectious Diseases, Genetics, Personalized Medicine), By End User (Hospitals, Diagnostic Centers, Research organizations, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Nucleic acid testing market size was valued at USD 3.1 billion in 2022 and  is poised to grow at a significant CAGR 6.3% from 2023-2029. Nucleic acid testing market report gives a comprehensive outlook on nucleic acid testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Nucleic acid testing market is estimated to grow at significant CAGR over the forecast years 2022-2028 due to an increase in the prevalence of certain types of cancers and infectious diseases across the globe. For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.

Global Nucleic Acid Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.3%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Nucleic Acid Testing Market Dynamics

Increase in the R&D for the development of newer products is a major factor drive the global nucleic acid testing market over the forecast years. For instance, in June 2018, Grifols received FDA approval for two blood screening assays: Procleix Ultrio Elite and Procleix WNV. Procleix Ultrio Elite to detect HIV 1, Hepatitis C, Hepatitis B, and HIV 2 based on nucleic acid testing. Moreover, raise in funding for R&D also boost the market over the forecast timeframe. For instance, in 2016, The National Cancer Institute has reserved $3.9 Bn to fund the establishment of laboratories to advance research on assays for cancers of the breast, prostate, lung, and genitourinary organs.

Global Nucleic Acid Testing Market Segmentation

By Technique
  • Probe Amplification
  • Target Amplification
  • Signal Amplification
By Application
  • Cancer, Infectious Diseases
  • Genetics
  • Personalized Medicine
By End User
  • Hospitals
  • Diagnostic Centers
  • Research organizations
  • Others

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Nucleic acid testing market size was valued at USD 3.1 billion in 2022 and  is poised to grow at a significant CAGR 6.3% from 2023-2029.

Asia-Pacific is the fastest-growing for Nucleic Acid Testing Market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis
1.Executive Summary
2.Global Nucleic Acid Testing Market Introduction 
2.1.Global Nucleic Acid Testing Market  - Taxonomy
2.2.Global Nucleic Acid Testing Market  - Definitions
2.2.1.Technique
2.2.2.Application 
2.2.3.End User
2.2.4.Region
3.Global Nucleic Acid Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Nucleic Acid Testing Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Nucleic Acid Testing Market  By Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Probe Amplification
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Target Amplification
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Signal Amplification
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Nucleic Acid Testing Market  By Application , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Cancer, Infectious Diseases
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Genetics
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Personalized Medicine
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Nucleic Acid Testing Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research organizations
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Nucleic Acid Testing Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Probe Amplification
9.1.2.Target Amplification
9.1.3.Signal Amplification
9.2.  Application  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cancer, Infectious Diseases
9.2.2.Genetics
9.2.3.Personalized Medicine
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Diagnostic Centers
9.3.3.Research organizations
9.3.4.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Probe Amplification
10.1.2.Target Amplification
10.1.3.Signal Amplification
10.2.  Application  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cancer, Infectious Diseases
10.2.2.Genetics
10.2.3.Personalized Medicine
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Diagnostic Centers
10.3.3.Research organizations
10.3.4.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Probe Amplification
11.1.2.Target Amplification
11.1.3.Signal Amplification
11.2.  Application  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cancer, Infectious Diseases
11.2.2.Genetics
11.2.3.Personalized Medicine
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Diagnostic Centers
11.3.3.Research organizations
11.3.4.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Probe Amplification
12.1.2.Target Amplification
12.1.3.Signal Amplification
12.2.  Application  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cancer, Infectious Diseases
12.2.2.Genetics
12.2.3.Personalized Medicine
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Diagnostic Centers
12.3.3.Research organizations
12.3.4.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Probe Amplification
13.1.2.Target Amplification
13.1.3.Signal Amplification
13.2.  Application  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cancer, Infectious Diseases
13.2.2.Genetics
13.2.3.Personalized Medicine
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Diagnostic Centers
13.3.3.Research organizations
13.3.4.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.bioMeriux, Inc.
14.2.2.Bio-rad Laboratories, Inc.
14.2.3.Abbott Laboratories
14.2.4.Hoffmann La Roche Ltd.
14.2.5.Qiagen N.V.
14.2.6.Becton, Dickinson and Company
14.2.7.Myriad Genetics, Inc.
14.2.8.Quest Diagnostics
14.2.9.Hologic, Inc.
14.2.10.Grifols S.A.
14.2.11.Illumina, Inc.
14.2.12.Siemens AG
14.2.13.Gen-Probe
14.2.14.Danaher Corporation
14.2.15.Merck KGaA
15. Research Methodology 
16. Appendix and Abbreviations 
  • bioMeriux, Inc.
  • Bio-rad Laboratories, Inc.
  • Abbott Laboratories
  • Hoffmann La Roche Ltd.
  • Qiagen N.V.
  • Becton, Dickinson and Company
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Hologic, Inc.
  • Grifols S.A.
  • Illumina, Inc.
  • Siemens AG
  • Gen-Probe
  • Danaher Corporation
  • Merck KGaA

Adjacent Markets